VIGOVITA Exhibited in 2024 CPHI China to Expand International Markets

Recently, SHANGHAI VIGOVITA BIOTECH CO., LTD. has successfully exhibited in 2024 CPHI Shanghai for three consecutive days starting from 19th June. This prestigious event brought together a global assembly of pharmaceutical ingredient manufacturers, suppliers, and professional visitors from around the world, providing an important platform for industry communication and cooperation.

Pic. 1

At this exhibition, VIGOVITA showcased its extensive range of pharmaceutical ingredients, including lincomycin, neomycin, and doxycycline. These products, known for their wide-ranging applications and stable supply-demand relationships, attracted significant attention and discussions from both domestic and international customers. Throughout the event, VIGOVITA booth was bustling with staff members providing detailed insights into the products' features and advantages, and answering various customer questions.

In addition, VIGOVITA engaged in in-depth conversations with several internationally renowned pharmaceutical companies during the exhibition, exploring potential cooperations. This event played a positive role for VIGOVITA to expand international market reach and enhance its brand awareness.

This exhibition enabled VIGOVITA to gain a deeper understanding of international market demands and trends, propelling the company's strategic initiative to actively explore global markets. In the future, the company will diversify its product range, select high-quality products, and enhance service levels to meet the diverse needs of both domestic and international markets. Additionally, the company will actively participate in more international exhibitions, deepening cooperation with global customers, and further enhancing its international brand influence.